These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21660259)

  • 1. Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification.
    Zheng CM; Lu KC; Wu CC; Hsu YH; Lin YF
    Int J Nephrol; 2011; 2011():939613. PubMed ID: 21660259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.
    Salem S; Bruck H; Bahlmann FH; Peter M; Passlick-Deetjen J; Kretschmer A; Steppan S; Volsek M; Kribben A; Nierhaus M; Jankowski V; Zidek W; Jankowski J
    Am J Nephrol; 2012; 35(1):31-9. PubMed ID: 22179063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of phosphate in vascular calcification.
    Giachelli CM
    Kidney Int; 2009 May; 75(9):890-7. PubMed ID: 19145240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure.
    Cernaro V; Longhitano E; Calabrese V; Casuscelli C; Di Carlo S; Spinella C; Gembillo G; Santoro D
    Expert Opin Pharmacother; 2023; 24(15):1737-1746. PubMed ID: 37527180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA FAS-AS1 served as a diagnostic biomarker of end-stage renal disease and mediated vascular calcification via regulating oxidative stress and inflammation.
    Wu J; Wan M; Jiang Z; Gong W; Zhou X
    Gene; 2024 Feb; 896():148035. PubMed ID: 38013128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.
    Qunibi WY; Nolan CA; Ayus JC
    Kidney Int Suppl; 2002 Dec; (82):S73-80. PubMed ID: 12410860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA; Shepler BM
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and Management of Vascular Calcification in Patients with End-Stage Renal Disease.
    Ogawa T; Nitta K
    Contrib Nephrol; 2018; 196():71-77. PubMed ID: 30041207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of hyperphosphatemia in vascular calcification].
    Shioi A; Nishizawa Y
    Clin Calcium; 2009 Feb; 19(2):180-5. PubMed ID: 19182356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate Toxicity and Vascular Calcification in Chronic Kidney Disease: A Closer Look Utilizing Transmission Electron Microscopy.
    Yang Y; Yang K; Xiong Y; He Y; Zhou Y; Hayden MR
    Curr Protein Pept Sci; 2023; 24(8):621-639. PubMed ID: 37496135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic kidney disease (CKD) and bone. Vascular calcification in CKD].
    Yokoyama K
    Clin Calcium; 2009 Apr; 19(4):552-8. PubMed ID: 19329835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia.
    Yamada S; Tokumoto M; Tsuruya K; Tatsumoto N; Noguchi H; Kitazono T; Ooboshi H
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F744-54. PubMed ID: 26180236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
    West SL; Swan VJ; Jamal SA
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease.
    Shigematsu T; Sonou T; Ohya M; Yokoyama K; Yoshida H; Yokoo T; Okuda K; Masumoto AR; Iwashita Y; Iseki K; Kunimoto S; Yamano Y
    Contrib Nephrol; 2017; 189():169-177. PubMed ID: 27951564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Evidence for a Causal Role of Serum Phosphate in Coronary Artery Calcification: The Rotterdam Study.
    Campos-Obando N; Bosman A; Kavousi M; Medina-Gomez C; van der Eerden BCJ; Bos D; Franco OH; Uitterlinden AG; Zillikens MC
    J Am Heart Assoc; 2022 Aug; 11(15):e023024. PubMed ID: 35904204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperphosphatemia and Cardiovascular Disease.
    Zhou C; Shi Z; Ouyang N; Ruan X
    Front Cell Dev Biol; 2021; 9():644363. PubMed ID: 33748139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients.
    Shigematsu T; Kono T; Satoh K; Yokoyama K; Yoshida T; Hosoya T; Shirai K
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii86-9. PubMed ID: 12771310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.